Xcout Intel
Cellestial Health
Cellestial Health is a privately held therapeutics development company spun out from the University of Cambridge in 2023 to create new treatments for Parkinson's disease and related conditions.
Subscribe to see Cellestial Health’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Cellestial Health at a glance
Cellestial Health is a healthcare company headquartered in United Kingdom, founded in 2023. Its most recent funding round, Pre-Seed, raised $654,000 in May 2025. Xcout tracks 1 named person at Cellestial Health, including Nat Hastings (CEO).
Cellestial Health leadership
- Nat HastingsCEO
Cellestial Health funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Pre-Seed | $654,000 | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Cellestial Health competitors
A few of Cellestial Health's closest competitors — see the full list of competitors and alternatives →
Neusignal Therapeutics, Inc. is a Tokyo-based company focused on commercializing early-stage drug discovery from Tohoku with the goal of defeating dementia.
Headquartered in Clermont-Ferrand, France, Axoltis Pharma is a biotechnology company focused on developing novel therapeutic solutions to restore blood-brain barrier integrity and treat neurodegenerative diseases.
CardiaTec Biosciences is a biotechnology research company headquartered in Cambridge, United Kingdom, focused on AI-driven cardiovascular discovery.
Herantis Pharma Oyj is a clinical-stage biotechnology company that develops disease-modifying therapies to halt or reverse the progression of neurodegenerative diseases. The company focuses on researching and advancing innovative treatments, such as its lead drug candidate HER-096, to address significant unmet medical needs.
Full Circles Therapeutics Inc. is a biotechnology company headquartered in Cambridge, Massachusetts. The company focuses on therapeutic innovations and engages in in vivo cell research collaborations.
Argobio is a startup studio located in Paris, France, dedicated to biotechnology and novel therapeutics. The organization operates at the intersection of academia and venture capital to transform scientific discoveries into de-risked pharmaceutical companies.
Get Cellestial Health's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Cellestial Health in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access